The previous page is sending you to https://pipelinereview.com/index.php/2021102179472/Antibodies/FDA-Expands-Approval-of-Dupixent-dupilumab-to-Include-Children-Aged-6-to-11-Years-with-Moderate-to-severe-Asthma.html.

 If you do not want to visit that page, you can return to the previous page.